Viatronix V3D-Colon software exclusively used clinical trial on CT Colonography

October 9, 2013 — Viatronix Inc. announced its dedicated CT Colonography (CTC) software V3D-Colon was exclusively used in another important clinical study relating to colorectal cancer screening. The latest CTC study, "Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history" (Lancet Oncology) tracked polyp growth in 243 patients over an eight year period.

For the first time, there is direct evidence and statistical proof that colorectal polyp-volume growth, over time, delivers true clinical value for identifying advanced adenomas. The advanced adenoma polyp is the primary target in colorectal cancer screening. When an advanced adenoma polyp is identified and removed, the likelihood of colorectal cancer developing is significantly reduced.

For more information: www.viatronix.com